Skip to main content
Caplight Logo









Hipro Biotechnology

Hipro Biotechnology

Private
ShijiazhuangHealthcare & Life Scienceshttps://hipro.us

Company Overview

Hipro Biotechnology operates in Healthcare & Life Sciences and is based in Shijiazhuang. It was founded in 2006.

Hipro Biotechnology is a medical technology company that specializes in the research, development, and manufacturing of point-of-care testing (POCT) diagnostic systems and reagents.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Hipro Biotechnology Comparables

Compare Hipro Biotechnology with similar companies based on industry and business-model similarity.

Hipro Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chengdu VACURE Biotechnology Co., Ltd.
85%
Lansion Biotechnology Co., Ltd.
84%
Jiangsu Medomics Medical Technology Co., Ltd.
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Hipro Biotechnology Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Hipro Biotechnology. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 56% month-over-month.

  • Jan 7, 2026

    Monthly visitors increased 43% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Hipro Biotechnology Filings

Explore SEC and related filing metadata, where available.

Hipro Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Hipro Biotechnology's valuation, stock price, and market status.

Is Hipro Biotechnology a public or private company?

Hipro Biotechnology is a private company.

What is the current stock price of Hipro Biotechnology?

Hipro Biotechnology is a private company, so its shares have no public market price. Caplight tracks Hipro Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hipro Biotechnology worth (valuation)?

Valuation information for Hipro Biotechnology is not publicly available.

Can I buy Hipro Biotechnology stock?

Hipro Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hipro Biotechnology's last funding round?

Funding round information for Hipro Biotechnology is not publicly available.

Who are the main investors in Hipro Biotechnology?

Investor information for Hipro Biotechnology is not publicly disclosed.

Will Hipro Biotechnology IPO soon?

No public IPO plans have been announced for Hipro Biotechnology.

How can I track Hipro Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades in Hipro Biotechnology's shares on secondary markets.

Firmographic Details

HeadquartersShijiazhuang
Employee Range9
Year Founded2006
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?